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ABSTRACT
MITOMAP (http://www.MITOMAP.org), a database for
the human mitochondrial genome, has grown rapidly
in data content over the past several years as interest
in the role of mitochondrial DNA (mtDNA) variation in
human origins, forensics, degenerative diseases,
cancer and aging has increased dramatically. To
accommodate this information explosion, MITOMAP
has implemented a new relational database and an
improved search engine, and all programs have
been rewritten. System administrative changes have
been made to improve security and efficiency, and to
make MITOMAP compatible with a new automatic
mtDNA sequence analyzer known as Mitomaster.
BACKGROUND
MITOMAP is a comprehensive database of human mitochon-
drial DNA (mtDNA) variation and its relationship with human
evolution and disease. The data content and operational tools
of MITOMAP have been expanded over the past ﬁve years, as
the importance of mtDNA variation to human health has
become increasingly apparent.
The mtDNA is a closed circular molecule of 16 569 nt. The
numbering system of the ‘Cambridge’ reference sequence
permits all the information in MITOMAP to be interrelated
through the affected nucleotide (1). The mtDNA codes for
37 genes, including a 12S and 16S rRNA, 22 tRNAs and
13 essential genes for oxidative phosphorylation (OXPHOS)
polypeptides. In addition, the mtDNA contains a 1000 nt
control region that encompasses transcription and replication
regulatory elements (2).
Mitochondria OXPHOS provides most of the cellular
energy,generatesmuchoftheendogenousreactiveoxygenspe-
cies (ROS) and regulates apoptosis through the mitochondrial
permeability transition pore (mtPTP). Each cell contains
hundreds to thousands of cytosolic, and thus maternally
inherited, mtDNAs. Because of its exposure to ROS, the
mtDNAhasaveryhighmutationrate,andnewmutationscreate
amixtureofmutantandnormalmtDNAswithinthecell,called
heteroplasmy.Asthe percentageofmutant mtDNAs increases,
mitochondrial energy production declines and ROS increases.
Increased ROS acts as a mitogen, but excessive ROS together
with reduced energy production can lead to apoptosis (2).
Human mtDNA variation correlates with the geographic
origin of the population harboring the mtDNA. This is because
mtDNAs harbor ancient polymorphisms that permitted our
ancestors to adapt to the increasing cold encountered as
they migrated out of Africa and into temperate Eurasia and
arctic Siberia [MXB1]. Today, these same variants are known
to affect human longevity and predisposition to neurode-
generative diseases such as Alzheimer’s disease (AD) and
Parkinson’s disease (PD) (3).
More recent germline mtDNA mutations have been linked
to a wide range of degenerative diseases, preferentially affect-
ing the central nervous system, heart, muscle, renal and endo-
crine systems. Pathogenic mtDNA mutations include mtDNA
rearrangements, base substitution mutations in the coding
region and also control-region mutations (2). Somatic
mtDNA rearrangement and base substitution mutations have
also been associated with aging (2). Indeed, different tissues
preferentially accumulate speciﬁc control region mutations,
suggesting that these mutations may affect important regula-
tory elements (4,5). This hypothesis has been supported by the
recent discovery that somatic mutations in key control-region
regulatory elements are elevated in AD brains (6).
Finally, mtDNA coding region and control-region muta-
tions are being found in a wide spectrum of cancers (7).
Increasingly, there is an evidence that these mtDNA play
an important role in neoplastic transformation (8).
The extraordinary array of clinically relevant mtDNA var-
iants makes it more important than ever that an authoritative
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over, it is now clear that seemingly unrelated mtDNA popula-
tion variation, age-related somatic mutations and inherited
pathogenic mutations can all contribute to an individual’s
predisposition to disease. Hence, being able to rapidly make
the appropriate associations via the mtDNA sequence of
ancient variants and recent mutations is critical for the proper
application of mtDNA analysis to forensics, anthropology, and
clinical and personalized medicine.
DATA
In MITOMAP, the location of each gene and regulatory-
functional element is deﬁned by its beginning and ending
nucleotide positions. Descriptions of the gene functions and
access to relevant references on the crystal structures of the
various respiratory complexes, when available, are provided.
A list of all currently known animal mtDNA sequences is also
maintained, which permits the alignment of the nucleotide and
amino acid sequence of each gene, permitting determination
of the evolutionary conservation of population and disease
associated amino acid sequence variants. A data ﬁle of the
diagnostic nucleotide sequence variants that deﬁne the various
population-speciﬁc mtDNA haplogroupsisalsomaintained,as
is a complete list of all known sequence polymorphisms.
MITOMAP also maintains a compendium of all known
pathogenic mtDNA mutations. These are divided into four
classes of mutations, each associated with its respective dis-
ease phenotype designation. The pathogenic mutation classes
are as follows: polypeptide mutations, protein synthesis
(rRNA and tRNA) mutations, rearrangement mutations and
control region mutations.
The amount of curated mtDNA data has grown enormously
in the past six years since the previous Nucleic Acids Research
report. Just in the past two years (September 2002–September
2004), the number of protein-coding gene mutations has
increased 44%, the number of protein synthesis mutations
has increased 58% and the number of somatic mutations
has increased 552% (see Table 1).
DATABASE
All of the data for MITOMAP is now managed in PostgreSQL
(http://www.postgresql.org/), an open-source database
management system (i.e. DBMS) with object-relational
modeling capabilities. The Georgia Tech Emory Networked
Object Management Environment (i.e. GENOME), used in the
previous version of MITOMAP, was an attempt to overcome
data-modeling limitations inherent in the DBMS initially
available to MITOMAP (9). However, in the intervening
years, an assortment of DBMSs with mature data-modeling
capabilities have become available which combine aspects of
both relational and object-oriented modeling. To accommo-
date the transition in DBMS, moderate changes were made to
the data schema so that it would adhere more strictly to the
principles governing relational design. These changes greatly
increased the ease of extending MITOMAP to include new
types of data and to be integrated with other systems.
Data management for MITOMAP is now performed in two
steps. New data extracted by the curator is initially stored,
formatted and screened in Excel spreadsheets. Updated ver-
sions of the curated data are then periodically uploaded to the
server, where Perl programs implementing the ParseExcel and
DBI modules are used to parse the values from the spread-
sheets and populate the data structures implemented in Post-
greSQL. Error screening is performed both by the curator and
by the population programs.
The hardware/server foundation of MITOMAP has
also been updated. Concurrent, with the relocation of the
MITOMAP servers to the University of California, Irvine,
MITOMAP has been moved to a dual-processor server
runningRedHat Linuxasitsoperatingsystem.Asecondserver
has also been added to handle the new systems being
integrated with MITOMAP.
INTERFACE
MITOMAP implements a dynamic web interface that allows
researchers to browse its collection of mtDNA variation and
references. Simple searches may be performed on all of the
data,whileadvancedsearch optionsareavailableforsearching
through the nearly 3000 references of mitochondrial related
literature.
The search engine, CGI scripts and all supporting programs
of MITOMAP were rewritten in the latest version of the Perl
programming language. The previous version of MITOMAP
had become a collection of programs in various languages,
making adjustments difﬁcult. The new CGI scripts utilize the
CGI.pm module (http://stein.cshl.org/WWW/software/CGI/)
for ease of development and maintainability (10). The
Table 1. MITOMAP data
1994 September 15, 2002 September 13, 2004 2002–2004
# Increase % Increase
References 629 2030 2944 914 45.02
Polymorphisms 743 1062 1532 470 44.26
mRNA mutations 25 59 93 34 57.63
rtRNA mutations 29 87 98 11 12.64
Deletions 77 97 106 9 9.28
Multiple deletions 64 69 70 1 1.45
Insertions
a 11 5 6 1 20.00
Rearrangements 0 7 8 1 14.29
Somatic mutations 0 21 137 116 552.38
Unpublished polymorphisms 0 205 648 443 216.10
aInsertions data were divided into Rearrangements and Insertions in 1995.
D612 Nucleic Acids Research, 2005, Vol. 33, Database issueApache web server was also updated and conﬁgured to use
modperl, an embedded Perl interpreter, for better security and
performance.
EXPERT SYSTEM
The functionality of MITOMAP is being extended by integra-
tion with an analytical system (see Figure 1), called Mito-
master. Mitomaster provides a component for processing
and analyzing biological information related to mitochondria,
and uses the information stored in MITOMAP as an important
part of its knowledgebase. While MITOMAP is a browsable
collection of information managed by a curator, Mitomaster is
designed to use this information for the analysis of new
information submitted by researchers. A clinical database,
Mitomed, is also being designed to integrate with these
systems.
CONCLUSION
MITOMAP has fulﬁlled its original goal of integrating
various domains of information related to the mitochondrial
genome. However, the proliferation of biological databases
and accumulation of vast quantities of data have created new
problems of system integration and data analysis. The changes
outlined here address these new challenges and will allow
MITOMAP to continue to serve as a model system. It is
reasonable to expect that as the volume and complexity of
information increases in other locus-speciﬁc databases, they
will beneﬁt from similar efforts at integration and expansion.
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Figure 1. Integration of MITOMAP with the analytical system Mitomaster and a clinical database called Mitomed.
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